学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
The epidermal growth factor receptor-tyrosine kinase: A promising therapeutic target in solid tumors
被引:156
作者
:
Ritter, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Hematol Oncol, Nashville, TN 37232 USA
Ritter, CA
Arteaga, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Hematol Oncol, Nashville, TN 37232 USA
Arteaga, CL
机构
:
[1]
Vanderbilt Univ, Sch Med, Div Hematol Oncol, Nashville, TN 37232 USA
[2]
Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[3]
Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA
[4]
Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA
来源
:
SEMINARS IN ONCOLOGY
|
2003年
/ 30卷
/ 01期
关键词
:
D O I
:
10.1053/sonc.2003.50027
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:3 / 11
页数:9
相关论文
共 71 条
[1]
Agus DB, 2000, SEMIN ONCOL, V27, P53
[2]
Development of inhibitors for protein tyrosine kinases
Al-Obeidi, FA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Calif Davis, Ctr Canc, Div Hematol Oncol, Sacramento, CA 95817 USA
Al-Obeidi, FA
Lam, KS
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Calif Davis, Ctr Canc, Div Hematol Oncol, Sacramento, CA 95817 USA
Lam, KS
[J].
ONCOGENE,
2000,
19
(49)
: 5690
-
5701
[3]
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
Albanell, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Albanell, J
Rojo, F
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Rojo, F
Averbuch, S
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Averbuch, S
Feyereislova, A
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Feyereislova, A
Mascaro, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Mascaro, JM
Herbst, R
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Herbst, R
LoRusso, P
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
LoRusso, P
Rischin, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Rischin, D
Sauleda, S
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Sauleda, S
Gee, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Gee, J
Nicholson, RI
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Nicholson, RI
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Baselga, J
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(01)
: 110
-
124
[4]
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
Anderson, NG
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Anderson, NG
Ahmad, T
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Ahmad, T
Chan, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Chan, K
Dobson, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Dobson, R
Bundred, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Bundred, NJ
[J].
INTERNATIONAL JOURNAL OF CANCER,
2001,
94
(06)
: 774
-
782
[5]
Arteaga CL, 2001, J CLIN ONCOL, V19, p32S
[6]
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
Bartlett, JMS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Bartlett, JMS
Langdon, SP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Langdon, SP
Simpson, BJB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Simpson, BJB
Stewart, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Stewart, M
Katsaros, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Katsaros, D
Sismondi, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Sismondi, P
Love, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Love, S
Scott, WN
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Scott, WN
Williams, ARW
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Williams, ARW
Lessells, AM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Lessells, AM
Macleod, KG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Macleod, KG
Smyth, JF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Smyth, JF
Miller, WR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Miller, WR
[J].
BRITISH JOURNAL OF CANCER,
1996,
73
(03)
: 301
-
306
[7]
ZD1839 ('Iressa')1,2 as an anticancer agent
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Gen Univ Valle Hebron, Div Med Oncol, Med Oncol Serv, Barcelona 08035, Spain
Baselga, J
Averbuch, SD
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Gen Univ Valle Hebron, Div Med Oncol, Med Oncol Serv, Barcelona 08035, Spain
Averbuch, SD
[J].
DRUGS,
2000,
60
(Suppl 1)
: 33
-
40
[8]
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Baselga, J
Pfister, D
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Pfister, D
Cooper, MR
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Cooper, MR
Cohen, R
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Cohen, R
Burtness, B
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Burtness, B
Bos, M
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Bos, M
D'Andrea, G
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
D'Andrea, G
Seidman, A
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Seidman, A
Norton, L
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Norton, L
Gunnett, K
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Gunnett, K
Falcey, J
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Falcey, J
Anderson, V
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Anderson, V
Waksal, H
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Waksal, H
Mendelsohn, J
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Mendelsohn, J
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2000,
18
(04)
: 904
-
914
[9]
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Baselga, J
Rischin, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Rischin, D
Ranson, M
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Ranson, M
Calvert, H
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Calvert, H
Raymond, E
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Raymond, E
Kieback, DG
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Kieback, DG
Kaye, SB
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Kaye, SB
Gianni, L
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Gianni, L
Harris, A
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Harris, A
Bjork, T
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Bjork, T
Averbuch, SD
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Averbuch, SD
Feyereislova, A
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Feyereislova, A
Swaisland, H
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Swaisland, H
Rojo, F
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Rojo, F
Albanell, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Albanell, J
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(21)
: 4292
-
4302
[10]
Type I Receptor Tyrosine Kinases as Targets for Therapy in Breast Cancer
Baselga, Jose
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Gen Univ Vall DHebron, Barcelona 08035, Spain
Hosp Gen Univ Vall DHebron, Barcelona 08035, Spain
Baselga, Jose
Mendelsohn, John
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
Hosp Gen Univ Vall DHebron, Barcelona 08035, Spain
Mendelsohn, John
[J].
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA,
1997,
2
(02)
: 165
-
174
←
1
2
3
4
5
6
7
8
→
共 71 条
[1]
Agus DB, 2000, SEMIN ONCOL, V27, P53
[2]
Development of inhibitors for protein tyrosine kinases
Al-Obeidi, FA
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Calif Davis, Ctr Canc, Div Hematol Oncol, Sacramento, CA 95817 USA
Al-Obeidi, FA
Lam, KS
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Calif Davis, Ctr Canc, Div Hematol Oncol, Sacramento, CA 95817 USA
Lam, KS
[J].
ONCOGENE,
2000,
19
(49)
: 5690
-
5701
[3]
Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
Albanell, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Albanell, J
Rojo, F
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Rojo, F
Averbuch, S
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Averbuch, S
Feyereislova, A
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Feyereislova, A
Mascaro, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Mascaro, JM
Herbst, R
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Herbst, R
LoRusso, P
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
LoRusso, P
Rischin, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Rischin, D
Sauleda, S
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Sauleda, S
Gee, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Gee, J
Nicholson, RI
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Nicholson, RI
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall Hebron Univ Hosp, Oncol Serv, Barcelona 08035, Spain
Baselga, J
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(01)
: 110
-
124
[4]
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
Anderson, NG
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Anderson, NG
Ahmad, T
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Ahmad, T
Chan, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Chan, K
Dobson, R
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Dobson, R
Bundred, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England
Bundred, NJ
[J].
INTERNATIONAL JOURNAL OF CANCER,
2001,
94
(06)
: 774
-
782
[5]
Arteaga CL, 2001, J CLIN ONCOL, V19, p32S
[6]
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
Bartlett, JMS
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Bartlett, JMS
Langdon, SP
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Langdon, SP
Simpson, BJB
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Simpson, BJB
Stewart, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Stewart, M
Katsaros, D
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Katsaros, D
Sismondi, P
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Sismondi, P
Love, S
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Love, S
Scott, WN
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Scott, WN
Williams, ARW
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Williams, ARW
Lessells, AM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Lessells, AM
Macleod, KG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Macleod, KG
Smyth, JF
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Smyth, JF
Miller, WR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV TURIN,DEPT GYNECOL ONCOL,TURIN,ITALY
Miller, WR
[J].
BRITISH JOURNAL OF CANCER,
1996,
73
(03)
: 301
-
306
[7]
ZD1839 ('Iressa')1,2 as an anticancer agent
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Gen Univ Valle Hebron, Div Med Oncol, Med Oncol Serv, Barcelona 08035, Spain
Baselga, J
Averbuch, SD
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Gen Univ Valle Hebron, Div Med Oncol, Med Oncol Serv, Barcelona 08035, Spain
Averbuch, SD
[J].
DRUGS,
2000,
60
(Suppl 1)
: 33
-
40
[8]
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Baselga, J
Pfister, D
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Pfister, D
Cooper, MR
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Cooper, MR
Cohen, R
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Cohen, R
Burtness, B
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Burtness, B
Bos, M
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Bos, M
D'Andrea, G
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
D'Andrea, G
Seidman, A
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Seidman, A
Norton, L
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Norton, L
Gunnett, K
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Gunnett, K
Falcey, J
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Falcey, J
Anderson, V
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Anderson, V
Waksal, H
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Waksal, H
Mendelsohn, J
论文数:
0
引用数:
0
h-index:
0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
Mendelsohn, J
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2000,
18
(04)
: 904
-
914
[9]
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types
Baselga, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Baselga, J
Rischin, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Rischin, D
Ranson, M
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Ranson, M
Calvert, H
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Calvert, H
Raymond, E
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Raymond, E
Kieback, DG
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Kieback, DG
Kaye, SB
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Kaye, SB
Gianni, L
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Gianni, L
Harris, A
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Harris, A
Bjork, T
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Bjork, T
Averbuch, SD
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Averbuch, SD
Feyereislova, A
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Feyereislova, A
Swaisland, H
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Swaisland, H
Rojo, F
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Rojo, F
Albanell, J
论文数:
0
引用数:
0
h-index:
0
机构:
Vall dHebron Univ Hosp, Dept Oncol, Barcelona 08035, Spain
Albanell, J
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2002,
20
(21)
: 4292
-
4302
[10]
Type I Receptor Tyrosine Kinases as Targets for Therapy in Breast Cancer
Baselga, Jose
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Gen Univ Vall DHebron, Barcelona 08035, Spain
Hosp Gen Univ Vall DHebron, Barcelona 08035, Spain
Baselga, Jose
Mendelsohn, John
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
Hosp Gen Univ Vall DHebron, Barcelona 08035, Spain
Mendelsohn, John
[J].
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA,
1997,
2
(02)
: 165
-
174
←
1
2
3
4
5
6
7
8
→